{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:04:51Z","timestamp":1747487091074},"reference-count":58,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.5551\/jat.63159","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T22:09:48Z","timestamp":1632521388000},"page":"1275-1284","source":"Crossref","is-referenced-by-count":6,"title":["Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication"],"prefix":"10.5551","volume":"29","author":[{"given":"Masato","family":"Furuhashi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Public Health, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukimura","family":"Higashiura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Nursing, Division of Medical and Behavioral Subjects, Sapporo Medical University School of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Shimamoto","sequence":"additional","affiliation":[{"name":"Japan Health Care College, President"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Public Health, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Artenstein AW, Opal SM: Proprotein convertases in health and disease. N Engl J Med, 2011; 365: 2507-2518","DOI":"10.1056\/NEJMra1106700"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Seidah NG, Prat A: The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov, 2012; 11: 367-383","DOI":"10.1038\/nrd3699"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Turpeinen H, Ortutay Z, Pesu M: Genetics of the first seven proprotein convertase enzymes in health and disease. Curr Genomics, 2013; 14: 453-467","DOI":"10.2174\/1389202911314050010"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK: The PCSK9 decade. J Lipid Res, 2012; 53: 2515-2524","DOI":"10.1194\/jlr.R026658"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Schmidt RJ, Zhang Y, Zhao Y, Qian YW, Wang H, Lin A, Ehsani ME, Yu X, Wang G, Singh J, Su EW, Li S, Konrad RJ, Cao G: A novel splicing variant of proprotein convertase subtilisin\/kexin type 9. DNA Cell Biol, 2008; 27: 183-189","DOI":"10.1089\/dna.2007.0667"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lagace TA, Curtis DE, Garuti R, McNutt MC, Park SW, Prather HB, Anderson NN, Ho YK, Hammer RE, Horton JD: Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest, 2006; 116: 2995-3005","DOI":"10.1172\/JCI29383"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nassoury N, Blasiole DA, Tebon Oler A, Benjannet S, Hamelin J, Poupon V, McPherson PS, Attie AD, Prat A, Seidah NG: The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR. Traffic, 2007; 8: 718-732","DOI":"10.1111\/j.1600-0854.2007.00562.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR, Committee FS, Investigators: Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med, 2017; 376: 1713-1722","DOI":"10.1056\/NEJMoa1615664"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM, Committees OO, Investigators: Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med, 2018; 379: 2097-2107","DOI":"10.1056\/NEJMoa1801174"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Li S, Zhang Y, Xu RX, Guo YL, Zhu CG, Wu NQ, Qing P, Liu G, Dong Q, Li JJ: Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease. Ann Med, 2015; 47: 386-393","DOI":"10.3109\/07853890.2015.1042908"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Furuhashi M, Omori A, Matsumoto M, Kataoka Y, Tanaka M, Moniwa N, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T: Independent Link Between Levels of Proprotein Convertase Subtilisin\/Kexin Type 9 and FABP4 in a General Population Without Medication. Am J Cardiol, 2016; 118: 198-203","DOI":"10.1016\/j.amjcard.2016.04.037"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S: Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy. J Atheroscler Thromb, 2022; 29: 24-37","DOI":"10.5551\/jat.58396"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Rousselet E, Benjannet S, Hamelin J, Canuel M, Seidah NG: The proprotein convertase PC7: unique zymogen activation and trafficking pathways. J Biol Chem, 2011; 286: 2728-2738","DOI":"10.1074\/jbc.M110.192344"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Molloy SS, Thomas L, Kamibayashi C, Mumby MC, Thomas G: Regulation of endosome sorting by a specific PP2A isoform. J Cell Biol, 1998; 142: 1399-1411","DOI":"10.1083\/jcb.142.6.1399"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gombojav B, Lee SJ, Kho M, Song YM, Lee K, Sung J: Multiple susceptibility loci at chromosome 11q23.3 are associated with plasma triglyceride in East Asians. J Lipid Res, 2016; 57: 318-324","DOI":"10.1194\/jlr.P063461"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kurano M, Tsukamoto K, Kamitsuji S, Kamatani N, Hara M, Ishikawa T, Kim BJ, Moon S, Jin Kim Y, Teramoto T: Genome-wide association study of serum lipids confirms previously reported associations as well as new associations of common SNPs within PCSK7 gene with triglyceride. J Hum Genet, 2016; 61: 427-433","DOI":"10.1038\/jhg.2015.170"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Peloso GM, Auer PL, Bis JC, Voorman A, Morrison AC, Stitziel NO, Brody JA, Khetarpal SA, Crosby JR, Fornage M, Isaacs A, Jakobsdottir J, Feitosa MF, Davies G, Huffman JE, Manichaikul A, Davis B, Lohman K, Joon AY, Smith AV, Grove ML, Zanoni P, Redon V, Demissie S, Lawson K, Peters U, Carlson C, Jackson RD, Ryckman KK, Mackey RH, Robinson JG, Siscovick DS, Schreiner PJ, Mychaleckyj JC, Pankow JS, Hofman A, Uitterlinden AG, Harris TB, Taylor KD, Stafford JM, Reynolds LM, Marioni RE, Dehghan A, Franco OH, Patel AP, Lu Y, Hindy G, Gottesman O, Bottinger EP, Melander O, Orho-Melander M, Loos RJ, Duga S, Merlini PA, Farrall M, Goel A, Asselta R, Girelli D, Martinelli N, Shah SH, Kraus WE, Li M, Rader DJ, Reilly MP, McPherson R, Watkins H, Ardissino D, Project NGES, Zhang Q, Wang J, Tsai MY, Taylor HA, Correa A, Griswold ME, Lange LA, Starr JM, Rudan I, Eiriksdottir G, Launer LJ, Ordovas JM, Levy D, Chen YD, Reiner AP, Hayward C, Polasek O, Deary IJ, Borecki IB, Liu Y, Gudnason V, Wilson JG, van Duijn CM, Kooperberg C, Rich SS, Psaty BM, Rotter JI, O\u2019Donnell CJ, Rice K, Boerwinkle E, Kathiresan S, Cupples LA: Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet, 2014; 94: 223-232","DOI":"10.1016\/j.ajhg.2014.01.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Stickel F, Buch S, Zoller H, Hultcrantz R, Gallati S, Osterreicher C, Finkenstedt A, Stadlmayr A, Aigner E, Sahinbegovic E, Sarrazin C, Schafmayer C, Braun F, Erhart W, Nothnagel M, Lerch MM, Mayerle J, Volzke H, Schaller A, Kratzer W, Boehm BO, Sipos B, D\u2019Amato M, Torkvist L, Stal P, Arlt A, Franke A, Becker T, Krawczak M, Zwerina J, Berg T, Hinrichsen H, Krones E, Dejaco C, Strasser M, Datz C, Hampe J: Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Hum Mol Genet, 2014; 23: 3883-3890","DOI":"10.1093\/hmg\/ddu076"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pelucchi S, Galimberti S, Greni F, Rametta R, Mariani R, Pelloni I, Girelli D, Busti F, Ravasi G, Valsecchi MG, Valenti L, Piperno A: Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis. J Gastroenterol Hepatol, 2016; 31: 1342-1348","DOI":"10.1111\/jgh.13315"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Oexle K, Ried JS, Hicks AA, Tanaka T, Hayward C, Bruegel M, Gogele M, Lichtner P, Muller-Myhsok B, Doring A, Illig T, Schwienbacher C, Minelli C, Pichler I, Fiedler GM, Thiery J, Rudan I, Wright AF, Campbell H, Ferrucci L, Bandinelli S, Pramstaller PP, Wichmann HE, Gieger C, Winkelmann J, Meitinger T: Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. Hum Mol Genet, 2011; 20: 1042-1047","DOI":"10.1093\/hmg\/ddq538"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Guillemot J, Canuel M, Essalmani R, Prat A, Seidah NG: Implication of the proprotein convertases in iron homeostasis: proprotein convertase 7 sheds human transferrin receptor 1 and furin activates hepcidin. Hepatology, 2013; 57: 2514-2524","DOI":"10.1002\/hep.26297"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003; 37: 917-923","DOI":"10.1053\/jhep.2003.50161"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med, 2005; 143: 722-728","DOI":"10.7326\/0003-4819-143-10-200511150-00009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Dongiovanni P, Meroni M, Baselli G, Mancina RM, Ruscica M, Longo M, Rametta R, Cespiati A, Pelusi S, Ferri N, Ranzani V, Nobili V, Pihlajamaki J, Fracanzani AL, Badiali S, Petta S, Fargion S, Romeo S, Kozlitina J, Valenti L: PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients. J Lipid Res, 2019; 60: 1144-1153","DOI":"10.1194\/jlr.P090449"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C: The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol, 2006; 6: 33","DOI":"10.1186\/1471-230X-6-33"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ishimura S, Furuhashi M, Watanabe Y, Hoshina K, Fuseya T, Mita T, Okazaki Y, Koyama M, Tanaka M, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Miura T: Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS ONE, 2013; 8: e81318","DOI":"10.1371\/journal.pone.0081318"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Furuhashi M, Matsumoto M, Tanaka M, Moniwa N, Murase T, Nakamura T, Ohnishi H, Saitoh S, Shimamoto K, Miura T: Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population. Circ J, 2018; 82: 1892-1899","DOI":"10.1253\/circj.CJ-18-0082"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419","DOI":"10.1007\/BF00280883"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Declercq J, Ramos-Molina B, Sannerud R, Brouwers B, Pruniau V, Meulemans S, Plets E, Annaert W, Creemers JWM: Endosome to trans-Golgi network transport of Proprotein Convertase 7 is mediated by a cluster of basic amino acids and palmitoylated cysteines. Eur J Cell Biol, 2017; 96: 432-439","DOI":"10.1016\/j.ejcb.2017.03.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day IN, Kivimaki M, Whittaker J, Humphries SE, Hingorani AD, investigators A, investigators N, Consortium B: Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet, 2009; 85: 628-642","DOI":"10.1016\/j.ajhg.2009.10.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Cui G, Li Z, Li R, Huang J, Wang H, Zhang L, Ding H, Wang DW: A functional variant in APOA5\/A4\/C3\/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. J Am Coll Cardiol, 2014; 64: 267-277","DOI":"10.1016\/j.jacc.2014.03.050"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM: Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol, 2014; 34: 1069-1077","DOI":"10.1161\/ATVBAHA.114.303284"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yao C, Chen BH, Joehanes R, Otlu B, Zhang X, Liu C, Huan T, Tastan O, Cupples LA, Meigs JB, Fox CS, Freedman JE, Courchesne P, O\u2019Donnell CJ, Munson PJ, Keles S, Levy D: Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes. Circulation, 2015; 131: 536-549","DOI":"10.1161\/CIRCULATIONAHA.114.010696"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science, 2001; 294: 169-173","DOI":"10.1126\/science.1064852"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ashraf Y, Duval S, Sachan V, Essalmani R, Susan-Resiga D, Roubtsova A, Hamelin J, Gerhardy S, Kirchhofer D, Tagliabracci VS, Prat A, Kiss RS, Seidah NG: Proprotein convertase 7 (PCSK7) reduces apoA-V levels. FEBS J, 2020; 287: 3565-3578","DOI":"10.1111\/febs.15212"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Lei X, Shi F, Basu D, Huq A, Routhier S, Day R, Jin W: Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J Biol Chem, 2011; 286: 15747-15756","DOI":"10.1074\/jbc.M110.217638"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology, 2003; 37: 1202-1219","DOI":"10.1053\/jhep.2003.50193"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Papagianni M, Sofogianni A, Tziomalos K: Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. World J Hepatol, 2015; 7: 638-648","DOI":"10.4254\/wjh.v7.i4.638"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Koyama M, Ohnishi H, Numata K, Hisasue T, Hanawa N, Moniwa N, Tsuchihashi K, Miura T: High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. Sci Rep, 2021; (in press):","DOI":"10.1038\/s41598-021-92292-y"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Jager S, Jacobs S, Kroger J, Stefan N, Fritsche A, Weikert C, Boeing H, Schulze MB: Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study. PLoS ONE, 2015; 10: e0124749","DOI":"10.1371\/journal.pone.0124749"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-Garcia C, Mancera J, Goday A, Mundet-Tuduri X, Regidor E, Group PS: Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLoS ONE, 2018; 13: e0198327","DOI":"10.1371\/journal.pone.0198327"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Olubamwo OO, Virtanen JK, Pihlajamaki J, Tuomainen TP: Association of fatty liver disease with mortality outcomes in an Eastern Finland male cohort. BMJ Open Gastroenterol, 2019; 6: e000219","DOI":"10.1136\/bmjgast-2018-000219"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Mori K, Koyama M, Ohnishi H, Moniwa N, Numata K, Hisasue T, Hanawa N, Miura T: Elevated fatty liver index is independently associated with new onset of hypertension during a 10-year period in both male and female subjects. J Am Heart Assoc, 2021; (in press):","DOI":"10.1161\/JAHA.121.021430"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Huh JH, Ahn SV, Koh SB, Choi E, Kim JY, Sung KC, Kim EJ, Park JB: A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. PLoS ONE, 2015; 10: e0143560","DOI":"10.1371\/journal.pone.0143560"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Bonnet F, Gastaldelli A, Pihan-Le Bars F, Natali A, Roussel R, Petrie J, Tichet J, Marre M, Fromenty B, Balkau B, D.E.S.I.R RSG: Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies. J Hypertens, 2017; 35: 493-500","DOI":"10.1097\/HJH.0000000000001204"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Roh JH, Park JH, Lee H, Yoon YH, Kim M, Kim YG, Park GM, Lee JH, Seong IW: A Close Relationship between Non-Alcoholic Fatty Liver Disease Marker and New-Onset Hypertension in Healthy Korean Adults. Korean Circ J, 2020; 50: 695-705","DOI":"10.4070\/kcj.2019.0379"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Takahashi S, Tanaka M, Furuhashi M, Moniwa N, Koyama M, Higashiura Y, Osanami A, Gocho Y, Ohnishi H, Numata K, Hisasue T, Hanawa N, Miura T: Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. Sci Rep, 2021; 11: 8606","DOI":"10.1038\/s41598-021-88025-w"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Zeng J, Sun C, Sun WL, Chen GY, Pan Q, Yan SY, Xu ZJ, Chen YW, Fan JG: Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up. J Dig Dis, 2017; 18: 229-236","DOI":"10.1111\/1751-2980.12465"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Sun K, Lin D, Li F, Qi Y, Feng W, Yan L, Chen C, Ren M, Liu D: Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China. BMJ Open, 2018; 8: e019097","DOI":"10.1136\/bmjopen-2017-019097"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Huh JH, Kim JY, Choi E, Kim JS, Chang Y, Sung KC: The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study. PLoS ONE, 2017; 12: e0180951","DOI":"10.1371\/journal.pone.0180951"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Dongiovanni P, Fracanzani AL, Fargion S, Valenti L: Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol, 2011; 55: 920-932","DOI":"10.1016\/j.jhep.2011.05.008"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Rametta R, Fracanzani AL, Fargion S, Dongiovanni P: Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities? Curr Pharm Des, 2020; 26: 1025-1035","DOI":"10.2174\/1381612826666200131103018"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Villeneuve P, Feliciangeli S, Croissandeau G, Seidah NG, Mbikay M, Kitabgi P, Beaudet A: Altered processing of the neurotensin\/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study. J Neurochem, 2002; 82: 783-793","DOI":"10.1046\/j.1471-4159.2002.00988.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Wetsel WC, Rodriguiz RM, Guillemot J, Rousselet E, Essalmani R, Kim IH, Bryant JC, Marcinkiewicz J, Desjardins R, Day R, Constam DB, Prat A, Seidah NG: Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice. Proc Natl Acad Sci U S A, 2013; 110: 17362-17367","DOI":"10.1073\/pnas.1314698110"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Scamuffa N, Calvo F, Chretien M, Seidah NG, Khatib AM: Proprotein convertases: lessons from knockouts. FASEB J, 2006; 20: 1954-1963","DOI":"10.1096\/fj.05-5491rev"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Sumida Y, Yoneda M: Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol, 2018; 53: 362-376","DOI":"10.1007\/s00535-017-1415-1"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Klein-Szanto AJ, Bassi DE: Proprotein convertase inhibition: Paralyzing the cell\u2019s master switches. Biochem Pharmacol, 2017; 140: 8-15","DOI":"10.1016\/j.bcp.2017.04.027"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/9\/29_63159\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:31:02Z","timestamp":1715232662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/9\/29_63159\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63159","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"63159"}}